Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our ...
Catabasis Pharmaceuticals, Inc. CATB announced that it has entered into a partnership with Duchenne UK, a charity to fund its phase II study on the lead pipeline candidate edasalonexent, an NF-kB ...
Catabasis Pharma says that its acquisition of Quellis Biosciences was on a stock-for-stock basis. This has it offering up shares of CATB stock and Series X Preferred Stock in exchange for all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results